News Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles October 16, 2024 Read More » IMULDOSA INJECTION October 14, 2024 Read More » HYMPAVZI October 11, 2024 Read More » About 6% of U.S. Adults Have ADHD, Drug Shortages Are Affecting Treatment October 10, 2024 Read More » ITOVEBI TABLETS October 10, 2024 Read More » Anxiety Medications and Alcohol Interactions October 4, 2024 Read More » GENERIC DRUG APPROVALS October 1, 2024 Read More » OTULFI™ September 30, 2024 Read More » FLYRCADO September 27, 2024 Read More » Page1 Page2 Page3 Page4 Page5 … Page42 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles October 16, 2024 Read More »
About 6% of U.S. Adults Have ADHD, Drug Shortages Are Affecting Treatment October 10, 2024 Read More »